ERAMET (ER7.DE) Stock Fundamental Analysis
FRA:ER7 - Deutsche Boerse Ag - FR0000131757 - Common Stock - Currency: EUR
Taking everything into account, ER7 scores 2 out of 10 in our fundamental rating. ER7 was compared to 36 industry peers in the Metals & Mining industry. ER7 has a bad profitability rating. Also its financial health evaluation is rather negative. ER7 is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year ER7 was profitable.
ER7 had a negative operating cash flow in the past year.
Of the past 5 years ER7 4 years were profitable.
ER7 had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
ER7 has a worse Return On Assets (0.22%) than 66.67% of its industry peers.
ER7's Return On Equity of 0.97% is on the low side compared to the rest of the industry. ER7 is outperformed by 63.89% of its industry peers.
The Return On Invested Capital of ER7 (1.34%) is worse than 72.22% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ER7 is in line with the industry average of 7.09%.
The last Return On Invested Capital (1.34%) for ER7 is well below the 3 year average (7.29%), which needs to be investigated, but indicates that ER7 had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.22% | ||
| ROE | 0.97% | ||
| ROIC | 1.34% |
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.29%
ROIC(5y)7.73%
1.3 Margins
ER7 has a Profit Margin of 0.48%. This is in the lower half of the industry: ER7 underperforms 66.67% of its industry peers.
ER7's Profit Margin has declined in the last couple of years.
ER7's Operating Margin of 3.27% is on the low side compared to the rest of the industry. ER7 is outperformed by 66.67% of its industry peers.
ER7's Operating Margin has declined in the last couple of years.
ER7's Gross Margin of 66.89% is amongst the best of the industry. ER7 outperforms 86.11% of its industry peers.
In the last couple of years the Gross Margin of ER7 has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.27% | ||
| PM (TTM) | 0.48% | ||
| GM | 66.89% |
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ER7 is destroying value.
ER7 has more shares outstanding than it did 1 year ago.
ER7 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ER7 has an improved debt to assets ratio.
2.2 Solvency
ER7 has an Altman-Z score of 1.12. This is a bad value and indicates that ER7 is not financially healthy and even has some risk of bankruptcy.
ER7 has a worse Altman-Z score (1.12) than 80.56% of its industry peers.
A Debt/Equity ratio of 1.35 is on the high side and indicates that ER7 has dependencies on debt financing.
ER7 has a worse Debt to Equity ratio (1.35) than 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.12 |
ROIC/WACC0.15
WACC8.97%
2.3 Liquidity
A Current Ratio of 1.64 indicates that ER7 should not have too much problems paying its short term obligations.
ER7 has a Current ratio of 1.64. This is in the lower half of the industry: ER7 underperforms 61.11% of its industry peers.
A Quick Ratio of 1.17 indicates that ER7 should not have too much problems paying its short term obligations.
ER7 has a better Quick ratio (1.17) than 69.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.64 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
ER7 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.47%.
Measured over the past years, ER7 shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -64.00% on average per year.
Looking at the last year, ER7 shows a decrease in Revenue. The Revenue has decreased by -9.78% in the last year.
The Revenue has been decreasing by -4.39% on average over the past years.
EPS 1Y (TTM)-88.47%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%406.32%
Revenue 1Y (TTM)-9.78%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-10.08%
3.2 Future
Based on estimates for the next years, ER7 will show a very strong growth in Earnings Per Share. The EPS will grow by 31.30% on average per year.
The Revenue is expected to grow by 5.55% on average over the next years.
EPS Next Y-57.76%
EPS Next 2Y8.24%
EPS Next 3Y31.3%
EPS Next 5YN/A
Revenue Next Year5.37%
Revenue Next 2Y8.73%
Revenue Next 3Y5.55%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 109.12, which means the current valuation is very expensive for ER7.
Based on the Price/Earnings ratio, ER7 is valued a bit more expensive than 69.44% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.57, ER7 is valued quite expensively.
Based on the Price/Forward Earnings ratio of 26.47, the valuation of ER7 can be described as expensive.
Based on the Price/Forward Earnings ratio, ER7 is valued a bit more expensive than the industry average as 72.22% of the companies are valued more cheaply.
ER7's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 109.12 | ||
| Fwd PE | 26.47 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ER7 indicates a slightly more expensive valuation: ER7 is more expensive than 61.11% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.35 |
4.3 Compensation for Growth
ER7's earnings are expected to grow with 31.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.24%
EPS Next 3Y31.3%
5. Dividend
5.1 Amount
ER7 has a Yearly Dividend Yield of 2.87%.
ER7's Dividend Yield is a higher than the industry average which is at 3.20.
ER7's Dividend Yield is comparable with the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.87% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
307.14% of the earnings are spent on dividend by ER7. This is not a sustainable payout ratio.
DP307.14%
EPS Next 2Y8.24%
EPS Next 3Y31.3%
FRA:ER7 (6/12/2025, 7:00:00 PM)
46.92
-1.66 (-3.42%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners11.85%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap1.35B
Analysts76
Price Target65.18 (38.92%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.87% |
Yearly Dividend1.51
Dividend Growth(5Y)N/A
DP307.14%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.16%
PT rev (3m)-22.77%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-73.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 109.12 | ||
| Fwd PE | 26.47 | ||
| P/S | 0.46 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.94 | ||
| P/tB | 1.35 | ||
| EV/EBITDA | 9.35 |
EPS(TTM)0.43
EY0.92%
EPS(NY)1.77
Fwd EY3.78%
FCF(TTM)-28.23
FCFYN/A
OCF(TTM)-4.35
OCFYN/A
SpS101.98
BVpS50.1
TBVpS34.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.22% | ||
| ROE | 0.97% | ||
| ROCE | 1.92% | ||
| ROIC | 1.34% | ||
| ROICexc | 1.63% | ||
| ROICexgc | 1.82% | ||
| OM | 3.27% | ||
| PM (TTM) | 0.48% | ||
| GM | 66.89% | ||
| FCFM | N/A |
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.29%
ROIC(5y)7.73%
ROICexc(3y)10.98%
ROICexc(5y)11.38%
ROICexgc(3y)12.91%
ROICexgc(5y)13.43%
ROCE(3y)10.76%
ROCE(5y)11.32%
ROICexcg growth 3Y-56.22%
ROICexcg growth 5Y-25.38%
ROICexc growth 3Y-55.33%
ROICexc growth 5Y-24.94%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
F-Score2
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.9 | ||
| Cap/Depr | 454.97% | ||
| Cap/Sales | 23.42% | ||
| Interest Coverage | 0.56 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.64 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 1.12 |
F-Score2
WACC8.97%
ROIC/WACC0.15
Cap/Depr(3y)260.42%
Cap/Depr(5y)209.27%
Cap/Sales(3y)18.57%
Cap/Sales(5y)15.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.47%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%406.32%
EPS Next Y-57.76%
EPS Next 2Y8.24%
EPS Next 3Y31.3%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.78%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-10.08%
Revenue Next Year5.37%
Revenue Next 2Y8.73%
Revenue Next 3Y5.55%
Revenue Next 5YN/A
EBIT growth 1Y-23.81%
EBIT growth 3Y-50.34%
EBIT growth 5Y-22.39%
EBIT Next Year104.71%
EBIT Next 3Y37.27%
EBIT Next 5YN/A
FCF growth 1Y-61.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-161.27%
OCF growth 3YN/A
OCF growth 5YN/A